✦ LIBER ✦

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer

✍ Scribed by T. Yoshikawa; M. Sasako; S. Yamamoto; T. Sano; H. Imamura; K. Fujitani; H. Oshita; S. Ito; Y. Kawashima; N. Fukushima

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 145 KB
Volume: 96
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.6665

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy and surgery for locally adv

Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5-fluorouracil

✍ Dr J. Th. Plukker; R. C. J. Verschueren; N. H. Mulder; D. Th. Sleijfer; J. Grond 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 1 views

Meta-analysis of adjuvant chemotherapy a

Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer

✍ P. Sun; J.-B. Xiang; Z.-Y. Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

Neoadjuvant chemotherapy for patients wi

Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma : Effect on tumor cell microinvolvement of regional lymph nodes

✍ Karen Becker; Umberto Fumagalli; James D. Mueller; Ulrich Fink; J. Rüdiger Siewe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

## BACKGROUND. In a previous study the authors demonstrated, using immunohistochemical methods for epithelial antigens, that the regional lymph nodes of gastric adenocarcinoma contained individual tumor cells or small clusters of these cells (tumor cell microinvolvement [TCM]) in over 90% of cases

High-dose cisplatin for locally advanced

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

✍ Kathleen A. Havlin; John G. Kuhn; J. William Myers; Robert F. Ozols; Douglas E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

Phase II study of a modified combination

Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer

✍ Içli, Fikri; Karaoguz, Handan; Akbulut, Hakan; Dinçol, Dilek; Demirkazik, Ahmet; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Background: Based on the promising results of eap (etoposide, doxorubicin, and cisplatin) combination, a phase ii study of modified eap combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival. ## Method: Fifty-two consecutive patients

A phase ii study of the combination of e

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

✍ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc